A New Motivation for Heroin Use: Three Diabetic Cases
Keywords:
heroinAbstract
Opioids carry a high risk of addiction, but they are occasionally used as medical treatments due to their analgesic effects. Therefore, people begin using substances to relieve the pain caused by a chronic illness or, in some cases, to relieve psychiatric distress. However, to our knowledge, no cases have been reported in the literature of individuals who began using substances with the intention of treating diabetes—or regulating blood sugar—or developing addiction. This article will discuss the clinical experiences of three diabetic patients who began using heroin "in an attempt to treat their diabetes."
References
Sadock BJ, Sadock VA. Comprehensive Text Book of Psychiatry, Dilbaz N, Şengezer T (Çevirenler). 8. Baskı, Ankara: Güneş Tıp Kitapevi, 2006;2: 1265-1272.
Harrison TR, Beeson PB, Braunwald E, et all. İç Hastalıkları prensipleri, Yazıcı AE, Yazıcı K (Çevirenler). 15. Baskı, İstanbul: Nobel Tıp Kitapevleri, 2004; 2: 2567-2570.
Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003; 35: 106-111.
Savaş HA, Kalenderoğlu A, Selek S, Yumru M. Eroin kullanımı ile remisyona giren tedaviye dirençli obsesif kompulsif bozukluk: Olgu sunumu. 42. Ulusal Psikiyatri Kongresi Bildiri Kitabı 2006:
Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive-Compulsive Scale,I: Development, use, and reliability. Arc Gen Psyc 1989; 46: 1006
Lustman PJ, Griffith LS, Clouse RE, et al. Psychiatric illness and diabetes mellitus. Relationship of symptoms to glucose control. J Nerv Ment Dis 1986; 174:736–42.
Türkçapar MH, Akdemir A, Elverici ŞK et al. Yatarak tedavi gören bir grup alkol bağımlısında ek psikiyatrik hastalıklar, kişilik bozuklukları, depresyon ve kaygı düzeyleri. 3P Dergisi; 5:29-34.
Alterman AI, Cacciola JS. The antisocial personality disorder dignosis in substance abusers: problems and issues. J Nerv Ment Dis;179:401-9.
Smail P, Stockwell T, Canter S et al. Alcohol dependence and phobic anxiety states I: a prevalence study. Br J Psyc. 1983: 144:53-57.
Senjo M Obssesive-compulsive disorderin people that abuse codein. Acta psychiatr Scand; 1989 79:619-620.
Çakmak D, Saatçioğlu Ö. Bağımlılık ve anksiyete bozuklukları. Bağımlılık ve Komorbidite.1. Baskı, İstanbul: Özgül Matbaacılık, 2005: 46-96.
Khantzian EJ. The self medication hypothesis of substance use disorder: A reconsideration and recent applications. Harward Review of Psychiatry. 1997; 4:231-244.
Buckley PF. Substance abuse in schizophrenia. A review, 1998. J Clin Psyc 59;26-30.
Passariello N, Giugliano D, Quatraro A, et al. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metobolism. 1983; 32:1163-1165.
Passariello N, Giugliano D, Ceriello A, et al. Impaired insulin response to glucose but not to arginine in heroin addicts. J Endocrinol Invest. 1986; 9: 353-357.
Brandle M, Lehmann R, Maly FE, et al. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA (LEU(UUR)) gene mutation. Diabetes Care .2001; 24: 1253-1258.
Morley JE. The endocrinology of the opiates and opiod peptides. Metobolism. 1981; 30: 195-209.
Bouix O, Najimi A, Lenoir V, et al. Endogenous oploid peptides stimulate post-exercise insulin response to glucose in rats. Int J Sports Med. 1996; 17: 80-84.
Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care. 1984; 7: 92-98.
Fisher L, Chesla CA, Mullan JT, Skaff MM, Kan- ter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 2001; 24: 1751–1757.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25: 464–70.
Allison B, Grigsby, RJ, Anderson KE, et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 2002; 53: 1053–60.
Gülseren L, Hekimsoy Z, Gülseren Ş ve ark. Diabetes mellituslu hastalarda depresyon, anksiyete, yaşam kalitesi ve yeti yitimi. Türk Psikiyatri Dergisi 2001;12: 89–98.
Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol 2001; 57; 457– 478.
Geringer ES. Affective disorders and diabetes mellitus. Neuropsychological and Behavioral Aspects of Diabetes, Holmes CS (Ed), NewYork, Springer, 1990;239–272.
Özkan S. Psikiyatrik tıp: Konsültasyon- Liyezon Psikiyatrisi. Roche Müstehzarları Sanayi A.Ş. P.K.16-80622
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...